This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

12 Top Health Care Picks for Hedge Funds

Stocks in this article: PFE SNY JNJ WLP UNH TEVA AET ESRX MRK ABT VRX

By Meena Krishnamsetty

NEW YORK ( Insider Monkey) -- Insider Monkey follows hedge fund managers because they're the smartest investors around. They leave less to chance than do most investors. They go to great lengths to get an "edge" over ordinary investors.

Hedge fund managers also have the resources to do extensive research on public companies and they have access to experts who can guide them. We believe we are more likely to beat the market by imitating insiders and hedge funds than trading against them. Based on the transactions of nearly 350 hedge funds compiled by Insider Monkey, we present the list of top 12 healthcare stocks among hedge funds:

1. Pfizer (PFE - Get Report): A whopping 75 hedge funds had Pfizer in their portfolios last quarter. Hedge funds collectively own 3% of the outstanding shares. The stock returned more than 18% over the last 52 weeks. David Einhorn's Greenlight Capital owns the most, with $483 Million. He's followed by Fisher Asset Management's $452 Million, Maverick Capital's $410 Million, and Appaloosa Management's $300 Million (see David Tepper's hot stock picks).

2. Sanofi Aventis (SNY - Get Report): Sixty-four hedge funds had Sanofi in their portfolios last quarter. Hedge funds collectively own 1.5% of the outstanding shares. The stock returned an incredible 33% over the past 52-weeks. Ken Fisher's Fisher Asset Management has nearly 15 million shares of the stock after the second quarter 11% increase. As of the end of June, the fund had nearly $600 Million in Sanofi Aventis (see Ken Fisher's top stock picks). Sanofi Aventis has a dividend yield of 5%. Warren Buffett's Berkshire Hathaway comes in second with $163 Million.

3. Johnson & Johnson (JNJ - Get Report): Fifty-seven hedge funds had JNJ in their portfolios last quarter. Hedge funds collectively own 3.1% of the outstanding shares. The stock returned 14% over the past 52-weeks. The New Brunswick-based company is the maker of things like Band-Aids, Tylenol, and other products we use everyday, but don't really think about it. Johnson & Johnson has one investor in it that will make other shareholders sleep better at night: Warren Buffett ( check out Warren Buffett's top holdings here).

4. WellPoint (WLP): Fifty-five hedge funds had WellPoint in their portfolios last quarter. Hedge funds collectively own 11.6% of the outstanding shares. The stock returned 21% over the past 52 weeks. Owl Creek Asset Management has more shares -- nearly 4 million -- than any other fund we track.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,672.60 -141.38 -0.79%
S&P 500 2,051.82 -11.33 -0.55%
NASDAQ 4,757.8790 +7.4820 0.16%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs